Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reduced ejection fraction and type 2 diabetes

被引：0
|
作者：
Alghamdi, M. [1 ]
Singh, J. [1 ]
Lang, C. [1 ]
Mordi, I [1 ]
Khan, F. [1 ]
机构：
[1] Univ Dundee, Dundee, Scotland
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reducedejection fraction and type 2 diabetes
    El-Chouli, M.
    Barcella, C. A.
    Mohr, G. H.
    Mudalige, N.
    Folke, F.
    Torp-Pedersen, C.
    Bruun, N. E.
    Lindhardsen, J.
    Ahlehoff, O.
    Gislason, G.
    Skov, L.
    Eroglu, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [3] Prognostic significance of epicardial adipose tissue in heart failure with preserved and reduced ejection fraction
    Pugliese, N. R.
    De Biase, N.
    Mazzola, M.
    Paneni, F.
    Del Punta, L.
    Gargani, L.
    Mengozzi, A.
    Virdis, A.
    Nesti, L.
    Taddei, S.
    Flammer, A.
    Borlaug, B. A.
    Ruschitzka, F.
    Masi, S.
    EUROPEAN HEART JOURNAL, 2021, 42 : 820 - 820
  • [4] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [5] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [6] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [7] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Borghi, Claudio
    Cicero, Arrigo F. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 972
  • [8] Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure
    Perez-Belmonte, Luis M.
    Moreno-Santos, Inmaculada
    Gomez-Doblas, Juan J.
    Garcia-Pinilla, Jose M.
    Morcillo-Hidalgo, Luis
    Garrido-Sanchez, Lourdes
    Santiago-Fernandez, Concepcion
    Crespo-Leiro, Maria G.
    Carrasco-Chinchilla, Fernando
    Sanchez-Fernandez, Pedro L.
    de Teresa-Galvan, Eduardo
    Jimenez-Navarro, Manuel
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, 14 (09): : 891 - 895
  • [9] Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)
    Turgut, C.
    Fernando, J.
    Berry, C.
    Campbell, R. T.
    Docherty, K. F.
    Dreisbach, J. G.
    Jhund, P. S.
    Mangion, K.
    Mark, P. B.
    Mcmurray, J. J., V
    Osmanska, J.
    Roditi, G.
    Petrie, M. C.
    Sattar, N.
    Lee, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] Dapagliflozin pharmacokinetics is similar between patients with heart failure with reduced ejection fraction and patients with type 2 diabetes mellitus
    Melin, Johanna
    Parkinson, Joanna
    Hamren, Bengt
    Penland, Robert C.
    Boulton, David W.
    Tang, Weifeng
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (02) : 606 - 612
12345